Logo image of CPRI

CAPRI HOLDINGS LTD (CPRI) Stock Fundamental Analysis

USA - NYSE:CPRI - VGG1890L1076 - Common Stock

20.71 USD
-0.04 (-0.19%)
Last: 10/16/2025, 8:04:00 PM
20.71 USD
0 (0%)
After Hours: 10/16/2025, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CPRI. CPRI was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. CPRI may be in some trouble as it scores bad on both profitability and health. CPRI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CPRI was profitable.
In the past year CPRI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CPRI reported negative net income in multiple years.
Each year in the past 5 years CPRI had a positive operating cash flow.
CPRI Yearly Net Income VS EBIT VS OCF VS FCFCPRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

The Return On Assets of CPRI (-20.39%) is worse than 87.50% of its industry peers.
CPRI has a Return On Invested Capital of 1.48%. This is amonst the worse of the industry: CPRI underperforms 81.25% of its industry peers.
CPRI had an Average Return On Invested Capital over the past 3 years of 5.93%. This is significantly below the industry average of 12.15%.
The 3 year average ROIC (5.93%) for CPRI is well above the current ROIC(1.48%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -20.39%
ROE N/A
ROIC 1.48%
ROA(3y)-5.88%
ROA(5y)-1.5%
ROE(3y)-100.73%
ROE(5y)-54.59%
ROIC(3y)5.93%
ROIC(5y)7.29%
CPRI Yearly ROA, ROE, ROICCPRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

CPRI has a worse Operating Margin (1.82%) than 79.17% of its industry peers.
CPRI's Operating Margin has declined in the last couple of years.
The Gross Margin of CPRI (63.26%) is better than 85.42% of its industry peers.
In the last couple of years the Gross Margin of CPRI has grown nicely.
Industry RankSector Rank
OM 1.82%
PM (TTM) N/A
GM 63.26%
OM growth 3Y-59.47%
OM growth 5Y-34.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y1.54%
CPRI Yearly Profit, Operating, Gross MarginsCPRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

CPRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CPRI has more shares outstanding than it did 1 year ago.
CPRI has less shares outstanding than it did 5 years ago.
CPRI has a worse debt/assets ratio than last year.
CPRI Yearly Shares OutstandingCPRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CPRI Yearly Total Debt VS Total AssetsCPRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.25 indicates that CPRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
CPRI has a Altman-Z score of 2.25. This is in the lower half of the industry: CPRI underperforms 64.58% of its industry peers.
The Debt to FCF ratio of CPRI is 18.16, which is on the high side as it means it would take CPRI, 18.16 years of fcf income to pay off all of its debts.
CPRI has a Debt to FCF ratio of 18.16. This is comparable to the rest of the industry: CPRI outperforms 41.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 18.16
Altman-Z 2.25
ROIC/WACC0.18
WACC8.02%
CPRI Yearly LT Debt VS Equity VS FCFCPRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CPRI has a Current Ratio of 1.17. This is a normal value and indicates that CPRI is financially healthy and should not expect problems in meeting its short term obligations.
CPRI's Current ratio of 1.17 is on the low side compared to the rest of the industry. CPRI is outperformed by 89.58% of its industry peers.
A Quick Ratio of 0.61 indicates that CPRI may have some problems paying its short term obligations.
The Quick ratio of CPRI (0.61) is worse than 89.58% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.61
CPRI Yearly Current Assets VS Current LiabilitesCPRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

3

3. Growth

3.1 Past

CPRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.41%.
Measured over the past years, CPRI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -26.36% on average per year.
CPRI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.69%.
Measured over the past years, CPRI shows a decrease in Revenue. The Revenue has been decreasing by -4.36% on average per year.
EPS 1Y (TTM)-53.41%
EPS 3Y-48.61%
EPS 5Y-26.36%
EPS Q2Q%1150%
Revenue 1Y (TTM)-16.69%
Revenue growth 3Y-7.73%
Revenue growth 5Y-4.36%
Sales Q2Q%-25.3%

3.2 Future

Based on estimates for the next years, CPRI will show a very strong growth in Earnings Per Share. The EPS will grow by 46.93% on average per year.
CPRI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.49% yearly.
EPS Next Y59.68%
EPS Next 2Y45.06%
EPS Next 3Y39.87%
EPS Next 5Y46.93%
Revenue Next Year-22.03%
Revenue Next 2Y-10.01%
Revenue Next 3Y-5.92%
Revenue Next 5Y-2.49%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CPRI Yearly Revenue VS EstimatesCPRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
CPRI Yearly EPS VS EstimatesCPRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

CPRI is valuated correctly with a Price/Earnings ratio of 15.93.
Based on the Price/Earnings ratio, CPRI is valued a bit cheaper than the industry average as 64.58% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.31. CPRI is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 11.72 indicates a reasonable valuation of CPRI.
Based on the Price/Forward Earnings ratio, CPRI is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
CPRI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.85.
Industry RankSector Rank
PE 15.93
Fwd PE 11.72
CPRI Price Earnings VS Forward Price EarningsCPRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CPRI is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as CPRI.
Industry RankSector Rank
P/FCF 26.8
EV/EBITDA 15.92
CPRI Per share dataCPRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

CPRI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CPRI's earnings are expected to grow with 39.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y45.06%
EPS Next 3Y39.87%

0

5. Dividend

5.1 Amount

No dividends for CPRI!.
Industry RankSector Rank
Dividend Yield N/A

CAPRI HOLDINGS LTD

NYSE:CPRI (10/16/2025, 8:04:00 PM)

After market: 20.71 0 (0%)

20.71

-0.04 (-0.19%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners101.17%
Inst Owner Change-0.02%
Ins Owners2.24%
Ins Owner Change4.35%
Market Cap2.47B
Analysts68.42
Price Target26.12 (26.12%)
Short Float %8.05%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)87.12%
Min EPS beat(2)-102.84%
Max EPS beat(2)277.07%
EPS beat(4)1
Avg EPS beat(4)31.34%
Min EPS beat(4)-102.84%
Max EPS beat(4)277.07%
EPS beat(8)1
Avg EPS beat(8)-7.86%
EPS beat(12)4
Avg EPS beat(12)-5.36%
EPS beat(16)8
Avg EPS beat(16)3.29%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-1.48%
Max Revenue beat(2)2.88%
Revenue beat(4)1
Avg Revenue beat(4)-2.62%
Min Revenue beat(4)-10.23%
Max Revenue beat(4)2.88%
Revenue beat(8)1
Avg Revenue beat(8)-4.8%
Revenue beat(12)3
Avg Revenue beat(12)-3.35%
Revenue beat(16)7
Avg Revenue beat(16)-1.58%
PT rev (1m)1.99%
PT rev (3m)6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-56.13%
EPS NY rev (1m)-1.13%
EPS NY rev (3m)0.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.86%
Revenue NY rev (1m)-1.38%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 15.93
Fwd PE 11.72
P/S 0.59
P/FCF 26.8
P/OCF 12.98
P/B N/A
P/tB N/A
EV/EBITDA 15.92
EPS(TTM)1.3
EY6.28%
EPS(NY)1.77
Fwd EY8.53%
FCF(TTM)0.77
FCFY3.73%
OCF(TTM)1.6
OCFY7.71%
SpS35.04
BVpS-0.14
TBVpS-6.85
PEG (NY)0.27
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.39%
ROE N/A
ROCE 1.87%
ROIC 1.48%
ROICexc 1.52%
ROICexgc 1.91%
OM 1.82%
PM (TTM) N/A
GM 63.26%
FCFM 2.21%
ROA(3y)-5.88%
ROA(5y)-1.5%
ROE(3y)-100.73%
ROE(5y)-54.59%
ROIC(3y)5.93%
ROIC(5y)7.29%
ROICexc(3y)6.19%
ROICexc(5y)7.57%
ROICexgc(3y)13.19%
ROICexgc(5y)17.21%
ROCE(3y)7.5%
ROCE(5y)9.23%
ROICexcg growth 3Y-59.18%
ROICexcg growth 5Y-34.44%
ROICexc growth 3Y-56.73%
ROICexc growth 5Y-31.62%
OM growth 3Y-59.47%
OM growth 5Y-34.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y1.54%
F-Score5
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 18.16
Debt/EBITDA 6.55
Cap/Depr 55.68%
Cap/Sales 2.35%
Interest Coverage 0.9
Cash Conversion 75.4%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.61
Altman-Z 2.25
F-Score5
WACC8.02%
ROIC/WACC0.18
Cap/Depr(3y)97.7%
Cap/Depr(5y)82.67%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.41%
EPS 3Y-48.61%
EPS 5Y-26.36%
EPS Q2Q%1150%
EPS Next Y59.68%
EPS Next 2Y45.06%
EPS Next 3Y39.87%
EPS Next 5Y46.93%
Revenue 1Y (TTM)-16.69%
Revenue growth 3Y-7.73%
Revenue growth 5Y-4.36%
Sales Q2Q%-25.3%
Revenue Next Year-22.03%
Revenue Next 2Y-10.01%
Revenue Next 3Y-5.92%
Revenue Next 5Y-2.49%
EBIT growth 1Y-73.05%
EBIT growth 3Y-62.6%
EBIT growth 5Y-37.79%
EBIT Next Year156.25%
EBIT Next 3Y59.53%
EBIT Next 5Y43.48%
FCF growth 1Y-78.8%
FCF growth 3Y-35.61%
FCF growth 5Y-24.79%
OCF growth 1Y-71.81%
OCF growth 3Y-26.37%
OCF growth 5Y-20.03%